A multi-dimensional view on the etiology of Parkinson’s disease
Authors:
Open Access
- 14 October 2025
- journal article
- review article
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 11 (1) , 1-5
Abstract
Parkinson’s disease (PD) has been proposed to be a predominantly genetic versus a mainly environmental disease. We suggest to consider PD rather as a disease caused by multi-dimensional factors, including genetic and environmental, but also epigenetic and metabolic effects. This view is supported by very recently published data on the role of cytochromes P450 (P450s) as a model for a participation of different metabolic pathways to PD. P450s are involved in a broad variety of physiological reactions in the human body and, in addition, play a fundamental role in the detoxification of environmental compounds. Therefore, the majority of PD cases is likely based on a complex interplay between disturbances in genes and the corresponding proteins, which catalyze various metabolic pathways, as well as epigenetic, physiological and environmental effects contributing to PD symptoms. In this context, PD can be caused by one gene mutation (in rare cases), by a combination of variants in different genes, and by an association of environmental factors (e.g. pesticides) with such variants. Characterization of these factors in each individual patient opens up new avenues for a personalized therapy.Keywords
Funding Information
- Dr. Rolf M. Schwiete Stiftung
This publication has 38 references indexed in Scilit:
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesThe Lancet Neurology, 2019
- The genetic architecture of Parkinson's diseaseThe Lancet Neurology, 2019
- The Emerging Evidence of the Parkinson PandemicJournal of Parkinson’s Disease, 2018
- Environmental Enrichment Prevents Transcriptional Disturbances Induced by Alpha-Synuclein OverexpressionFrontiers in Cellular Neuroscience, 2018
- Agricultural activities and the incidence of Parkinson’s disease in the general French populationEuropean Journal of Epidemiology, 2017
- Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug InteractionsChemical Research in Toxicology, 2016
- MUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSETNeurology, 2009
- Inhibition of Cytochromes P450: Existing and New Promising Therapeutic TargetsDrug Metabolism Reviews, 2007
- The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysisJournal of the Neurological Sciences, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997